May 13, 2026 a 02:46 am
TMO: Dividend Analysis - Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides a modest dividend yield with a strong historical growth trajectory. The corporation consistently increases its dividend payouts, showcasing a commitment to returning value to shareholders. Although the current yield appears low, the company's sustainability and growth strategy underscore the potential for future gains.
📊 Overview
The financial health and sustainability of Thermo Fisher are supported by a strong market capitalization and a history of consistent dividend payments. The low dividend yield is balanced by the solid growth figures.
| Metric | Value |
|---|---|
| Sector | Health Care |
| Dividend Yield | 0.38% |
| Current Dividend Per Share | 1.69 USD |
| Dividend History | 18 years |
| Last Cut or Suspension | None |
🗣️ Dividend History
Analyzing the dividend history provides insight into the company's commitment to returning value to shareholders. Thermo Fisher has shown stable dividend growth, enhancing investor confidence.
| Year | Dividend Per Share (USD) |
|---|---|
| 2026 | 0.47 |
| 2025 | 1.72 |
| 2024 | 1.56 |
| 2023 | 1.40 |
| 2022 | 1.20 |
📈 Dividend Growth
The growth of dividends over time is paramount to assessing the potential future income from investments. Thermo Fisher's dividends have grown durably over the past few years, indicating robust financial strategies.
| Time | Growth |
|---|---|
| 3 years | 12.75% |
| 5 years | 14.34% |
The average dividend growth is 14.34% over 5 years. This shows moderate but steady dividend growth, underscoring Thermo Fisher's commitment to enhancing shareholder returns.
📉 Payout Ratio
The payout ratios provide a glimpse into how much of the company's earnings and free cash flows are being returned to shareholders in the form of dividends. Thermo Fisher maintains a conservative payout strategy, ensuring sustainability and room for growth.
| Key Figure | Ratio |
|---|---|
| EPS-based | 9.17% |
| Free cash flow-based | 9.32% |
With an EPS payout ratio of 9.17% and a free cash flow payout ratio of 9.32%, Thermo Fisher demonstrates a disciplined approach in dividend disbursement, allowing for financial flexibility.
✅ Cashflow & Capital Efficiency
Thermo Fisher exhibits efficient use of its capital and maintains a stabilizing cash flow for sustainable operations and future expansions.
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Free Cash Flow Yield | 2.88% | 3.65% | 3.38% |
| Earnings Yield | 3.09% | 3.19% | 2.92% |
| CAPEX to Operating Cash Flow | 19.50% | 16.15% | 17.59% |
| Stock-based Compensation to Revenue | 0% | 0.70% | 0.65% |
| Free Cash Flow / Operating Cash Flow Ratio | 80.49% | 83.85% | 82.41% |
Thermo Fisher shows reliable capital usage, where the stable free cash flow and investment ratios portend potential for continued profitability.
⚠️ Balance Sheet & Leverage Analysis
The company's leverage and liquidity positions are telling indicators of financial stability and operational resilience.
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Debt-to-Equity | 0.76 | 0.66 | 0.78 |
| Debt-to-Assets | 0.37 | 0.34 | 0.37 |
| Debt-to-Capital | 0.43 | 0.40 | 0.44 |
| Net Debt to EBITDA | 2.70 | 2.44 | 2.53 |
| Current Ratio | 0 | 0 | 0 |
| Quick Ratio | 1.53 | 1.29 | 1.39 |
| Financial Leverage | 2.07 | 1.96 | 2.11 |
The balance sheet remains strong, albeit with slightly rising leverage ratios, indicating a growing reliance on debt yet balanced with disciplined financial leverage.
✅ Fundamental Strength & Profitability
Thermo Fisher's profitability metrics reinforce its capability to generate returns and value, ensuring robust financial health and investor confidence.
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Return on Equity | 12.61% | 12.78% | 12.83% |
| Return on Assets | 6.11% | 6.51% | 6.07% |
| Margins: Net | 15.12% | 14.77% | 13.99% |
| Margins: EBIT | 19.49% | 20.27% | 18.17% |
| Margins: EBITDA | 25.73% | 27.52% | 26.12% |
| Margins: Gross | 37.66% | 41.34% | 40.12% |
| Research & Development to Revenue | 3.08% | 3.24% | 3.12% |
Strong returns on equity and assets assure that Thermo Fisher efficiently allocates its capital, reflected in robust profit margins across different operational levels.
📈 Price Development
Dividend Scoring System
| Criteria | Score | Score Bar |
|---|---|---|
| Dividend yield | 2 | |
| Dividend Stability | 5 | |
| Dividend growth | 4 | |
| Payout ratio | 5 | |
| Financial stability | 4 | |
| Dividend continuity | 5 | |
| Cashflow Coverage | 4 | |
| Balance Sheet Quality | 4 |
Total Score: 33/40
🔍 Rating
Thermo Fisher Scientific Inc. has cemented its position as a reliable dividend payer with strong growth prospects and financial stability. Despite a low current dividend yield, the potential for capital appreciation and steady dividend increases makes it a compelling choice for growth-oriented dividend investors.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years